Systematic evaluation of the miRNA-ome and its downstream effects on mRNA expression identifies gastric cancer progression

Oleg Tchernitsa, Atsuko Kasajima, Reinhold Schäfer, Ralf Jürgen Kuban, Ute Ungethüm, B. Györffy, Ulf Neumann, Eva Simon, Wilko Weichert, Matthias P A Ebert, Christoph Röcken

Research output: Contribution to journalArticle

97 Citations (Scopus)

Abstract

We investigated the differential expression of Dicer and Drosha, as well as that of microRNA (miRNA), in adjacent normal and tumour samples of patients with gastric cancer. The expression of Dicer and Drosha was studied by immunohistochemistry in 332 gastric cancers and correlated with clinico-pathological patient characteristics. Differential expression of miRNAs was studied using the Invitrogen NCode Multi-Species miRNA Microarray Probe Set containing 857 mammalian probes in a test set of six primary gastric cancers (three with and three without lymph node metastases). Differential expression was validated by RT-PCR on an independent validation set of 20 patients with gastric cancer. Dicer and Drosha were differentially expressed in non-neoplastic and neoplastic gastric tissue. The expression of Drosha correlated with local tumour growth and was a significant independent prognosticator of patient survival. Twenty miRNAs were up-and two down-regulated in gastric carcinoma compared with non-neoplastic tissue. Six of these miRNAs separated node-positive from node-negative gastric cancers, ie miR-103, miR-21, miR-145, miR-106b, miR-146a, and miR-148a. Five miRNAs expressed differentially in node-positive cancers had conserved binding sites for mRNAs differentially expressed in the same set of tumour samples. Gastric cancer shows a complex derangement of the miRNA-ome, including Dicer and Drosha. These changes correlate independently with patient prognosis and probably influence local tumour growth and nodal spread.

Original languageEnglish
Pages (from-to)310-319
Number of pages10
JournalJournal of Pathology
Volume222
Issue number3
DOIs
Publication statusPublished - 2010

Fingerprint

MicroRNAs
Stomach Neoplasms
Messenger RNA
Neoplasms
Stomach
Growth
Lymph Nodes
Immunohistochemistry
Binding Sites
Neoplasm Metastasis
Carcinoma
Polymerase Chain Reaction
Survival

Keywords

  • Dicer
  • Drosha
  • Gastric cancer
  • Lymph node metastases
  • MiRNA
  • Prognosis

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medicine(all)

Cite this

Systematic evaluation of the miRNA-ome and its downstream effects on mRNA expression identifies gastric cancer progression. / Tchernitsa, Oleg; Kasajima, Atsuko; Schäfer, Reinhold; Kuban, Ralf Jürgen; Ungethüm, Ute; Györffy, B.; Neumann, Ulf; Simon, Eva; Weichert, Wilko; Ebert, Matthias P A; Röcken, Christoph.

In: Journal of Pathology, Vol. 222, No. 3, 2010, p. 310-319.

Research output: Contribution to journalArticle

Tchernitsa, O, Kasajima, A, Schäfer, R, Kuban, RJ, Ungethüm, U, Györffy, B, Neumann, U, Simon, E, Weichert, W, Ebert, MPA & Röcken, C 2010, 'Systematic evaluation of the miRNA-ome and its downstream effects on mRNA expression identifies gastric cancer progression', Journal of Pathology, vol. 222, no. 3, pp. 310-319. https://doi.org/10.1002/path.2759
Tchernitsa, Oleg ; Kasajima, Atsuko ; Schäfer, Reinhold ; Kuban, Ralf Jürgen ; Ungethüm, Ute ; Györffy, B. ; Neumann, Ulf ; Simon, Eva ; Weichert, Wilko ; Ebert, Matthias P A ; Röcken, Christoph. / Systematic evaluation of the miRNA-ome and its downstream effects on mRNA expression identifies gastric cancer progression. In: Journal of Pathology. 2010 ; Vol. 222, No. 3. pp. 310-319.
@article{803aa0b5b50144cf9c740d3155b7ecd1,
title = "Systematic evaluation of the miRNA-ome and its downstream effects on mRNA expression identifies gastric cancer progression",
abstract = "We investigated the differential expression of Dicer and Drosha, as well as that of microRNA (miRNA), in adjacent normal and tumour samples of patients with gastric cancer. The expression of Dicer and Drosha was studied by immunohistochemistry in 332 gastric cancers and correlated with clinico-pathological patient characteristics. Differential expression of miRNAs was studied using the Invitrogen NCode™ Multi-Species miRNA Microarray Probe Set containing 857 mammalian probes in a test set of six primary gastric cancers (three with and three without lymph node metastases). Differential expression was validated by RT-PCR on an independent validation set of 20 patients with gastric cancer. Dicer and Drosha were differentially expressed in non-neoplastic and neoplastic gastric tissue. The expression of Drosha correlated with local tumour growth and was a significant independent prognosticator of patient survival. Twenty miRNAs were up-and two down-regulated in gastric carcinoma compared with non-neoplastic tissue. Six of these miRNAs separated node-positive from node-negative gastric cancers, ie miR-103, miR-21, miR-145, miR-106b, miR-146a, and miR-148a. Five miRNAs expressed differentially in node-positive cancers had conserved binding sites for mRNAs differentially expressed in the same set of tumour samples. Gastric cancer shows a complex derangement of the miRNA-ome, including Dicer and Drosha. These changes correlate independently with patient prognosis and probably influence local tumour growth and nodal spread.",
keywords = "Dicer, Drosha, Gastric cancer, Lymph node metastases, MiRNA, Prognosis",
author = "Oleg Tchernitsa and Atsuko Kasajima and Reinhold Sch{\"a}fer and Kuban, {Ralf J{\"u}rgen} and Ute Ungeth{\"u}m and B. Gy{\"o}rffy and Ulf Neumann and Eva Simon and Wilko Weichert and Ebert, {Matthias P A} and Christoph R{\"o}cken",
year = "2010",
doi = "10.1002/path.2759",
language = "English",
volume = "222",
pages = "310--319",
journal = "Journal of Pathology",
issn = "0022-3417",
publisher = "John Wiley and Sons Ltd",
number = "3",

}

TY - JOUR

T1 - Systematic evaluation of the miRNA-ome and its downstream effects on mRNA expression identifies gastric cancer progression

AU - Tchernitsa, Oleg

AU - Kasajima, Atsuko

AU - Schäfer, Reinhold

AU - Kuban, Ralf Jürgen

AU - Ungethüm, Ute

AU - Györffy, B.

AU - Neumann, Ulf

AU - Simon, Eva

AU - Weichert, Wilko

AU - Ebert, Matthias P A

AU - Röcken, Christoph

PY - 2010

Y1 - 2010

N2 - We investigated the differential expression of Dicer and Drosha, as well as that of microRNA (miRNA), in adjacent normal and tumour samples of patients with gastric cancer. The expression of Dicer and Drosha was studied by immunohistochemistry in 332 gastric cancers and correlated with clinico-pathological patient characteristics. Differential expression of miRNAs was studied using the Invitrogen NCode™ Multi-Species miRNA Microarray Probe Set containing 857 mammalian probes in a test set of six primary gastric cancers (three with and three without lymph node metastases). Differential expression was validated by RT-PCR on an independent validation set of 20 patients with gastric cancer. Dicer and Drosha were differentially expressed in non-neoplastic and neoplastic gastric tissue. The expression of Drosha correlated with local tumour growth and was a significant independent prognosticator of patient survival. Twenty miRNAs were up-and two down-regulated in gastric carcinoma compared with non-neoplastic tissue. Six of these miRNAs separated node-positive from node-negative gastric cancers, ie miR-103, miR-21, miR-145, miR-106b, miR-146a, and miR-148a. Five miRNAs expressed differentially in node-positive cancers had conserved binding sites for mRNAs differentially expressed in the same set of tumour samples. Gastric cancer shows a complex derangement of the miRNA-ome, including Dicer and Drosha. These changes correlate independently with patient prognosis and probably influence local tumour growth and nodal spread.

AB - We investigated the differential expression of Dicer and Drosha, as well as that of microRNA (miRNA), in adjacent normal and tumour samples of patients with gastric cancer. The expression of Dicer and Drosha was studied by immunohistochemistry in 332 gastric cancers and correlated with clinico-pathological patient characteristics. Differential expression of miRNAs was studied using the Invitrogen NCode™ Multi-Species miRNA Microarray Probe Set containing 857 mammalian probes in a test set of six primary gastric cancers (three with and three without lymph node metastases). Differential expression was validated by RT-PCR on an independent validation set of 20 patients with gastric cancer. Dicer and Drosha were differentially expressed in non-neoplastic and neoplastic gastric tissue. The expression of Drosha correlated with local tumour growth and was a significant independent prognosticator of patient survival. Twenty miRNAs were up-and two down-regulated in gastric carcinoma compared with non-neoplastic tissue. Six of these miRNAs separated node-positive from node-negative gastric cancers, ie miR-103, miR-21, miR-145, miR-106b, miR-146a, and miR-148a. Five miRNAs expressed differentially in node-positive cancers had conserved binding sites for mRNAs differentially expressed in the same set of tumour samples. Gastric cancer shows a complex derangement of the miRNA-ome, including Dicer and Drosha. These changes correlate independently with patient prognosis and probably influence local tumour growth and nodal spread.

KW - Dicer

KW - Drosha

KW - Gastric cancer

KW - Lymph node metastases

KW - MiRNA

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=77957978941&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957978941&partnerID=8YFLogxK

U2 - 10.1002/path.2759

DO - 10.1002/path.2759

M3 - Article

VL - 222

SP - 310

EP - 319

JO - Journal of Pathology

JF - Journal of Pathology

SN - 0022-3417

IS - 3

ER -